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Abstract Latrophilin is a brain-specific Ca2+-independent
receptor of K-latrotoxin, a potent presynaptic neurotoxin. We
now report the finding of two novel latrophilin homologues. All
three latrophilins are unusual G protein-coupled receptors. They
exhibit strong similarities within their lectin, olfactomedin and
transmembrane domains but possess variable C-termini. Latro-
philins have up to seven sites of alternative splicing; some splice
variants contain an altered third cytoplasmic loop or a truncated
cytoplasmic tail. Only latrophilin-1 binds K-latrotoxin; it is
abundant in brain and is present in endocrine cells. Latrophilin-3
is also brain-specific, whereas latrophilin-2 is ubiquitous.
Together, latrophilins form a novel family of heterogeneous G
protein-coupled receptors with distinct tissue distribution and
functions.
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1. Introduction
K-Latrotoxin (LTX), a potent activatory presynaptic toxin
from the black widow spider venom, is widely used as a tool
to study exocytosis [1]. The toxin binds to its receptors on
plasma membrane and stimulates massive release of neuro-
transmitters from neuronal, neuroendocrine and endocrine
cells [2^5]. In order to understand the functions of these re-
ceptors in LTX action and in the normal secretory process, it
is important to thoroughly investigate these proteins.
Two neuronal proteins are known to bind the toxin with
high a⁄nity, neurexin Ia [6,7] and the recently isolated latro-
philin (also called CIRL for Ca2-independent receptor of
K-latrotoxin) [8^11]. Neurexins are a family of neuronal cell-
surface proteins with one transmembrane domain, ubiquitous
distribution within the nervous system and an uncertain sig-
nalling mechanism [7,12,13]. Neurexin IK binds LTX only in
the presence of Ca2 and, therefore, cannot mediate the toxin
action in the absence of this cation [14]. Latrophilin is a G
protein-coupled receptor (GPCR) with an unusual structure.
Its physical and functional coupling to G proteins [11,15]
makes it suited for signal transduction into the cell. Latrophi-
lin, which is expressed in nerve terminals of neurones and in
endocrine cells, binds LTX both in the presence and in the
absence of Ca2 ([8,11,14,16] ; Ushkaryov, unpublished).
In the process of cloning and sequencing of latrophilin [11],
we found several homologous proteins. Herein, we report the
complete structure of bovine latrophilin (LPH1) and two of its
homologues, termed latrophilin-2 and latrophilin-3 (LPH2
and LPH3). Our results reveal that all latrophilins possess
the same architecture as unusual GPCRs, whilst multiple al-
ternative splicing makes these proteins highly variable. Di¡er-
ential tissue distribution of latrophilins and the ability of only
LPH1 to bind LTX suggest distinct functions for the members
of this family of receptors.
2. Materials and methods
The full size insert from the rat latrophilin clone R9-15 [11] was
used for conventional screening of a bovine brain oligo(dT)-primed
cDNA library in VZAP II (Stratagene). Forty-nine independent clones
were isolated in three initial rounds of screening. As none of these
clones contained the 5P-end of the corresponding cDNAs, a randomly
primed bovine brain cDNA library in Vgt10 (Clontech) was hybridised
using latrophilin type-speci¢c probes. A further ¢ve rounds of screen-
ing yielded the total of 27 LPH1 clones, 35 LPH2 clones, and 19
LPH3 clones. Partial or complete sequences of all inserts were deter-
mined on an ABI PRISM automated sequencer, using synthetic oli-
gonucleotides as primers and the ABI Dye Terminator Cycle Sequenc-
ing Kit with AmpliTaq DNA polymerase according to the
manufacturer’s instructions (Perkin-Elmer). Sequences were analysed
using the Lasergene software package (DNAStar). Current database
searches were conducted on-line using the BLAST program; PEST
motifs were identi¢ed with the help of PEST-FIND software. Nucleo-
tide sequences of bovine LPHs and their splice variants determined in
this work have been submitted to GenBank under accession numbers
AF111069^AF111099.
Hybridisation of rat multiple tissue RNA blots was carried out as
suggested by the manufacturer (Clontech). The longest inserts from
rat or bovine latrophilin cDNA clones were used as probes. A⁄nity
chromatography of brain and liver membranes and Western blotting
of protein fractions was performed as described [8].
3. Results and discussion
3.1. Molecular cloning of bovine latrophilin and its homologues
Using a⁄nity chromatography of solubilised bovine brain
membranes, we puri¢ed latrophilin and determined the struc-
ture of four peptides isolated from this protein after its tryp-
sinolysis [11]. Sequences of these peptides (YDLRTRIK,
SGETVINTANYHDT, SGENAANIASELAR, and LA-
GEAGSGG, in the single-letter amino acid code) were used
to verify the identity of clones isolated from the bovine brain
cDNA library. Among these, we found two groups of clones
that contained sequences which were distantly homologous to
rat LPH [11] but which did not match exactly the peptides
from the bovine brain protein. Proteins encoded by these
cDNAs were termed bovine LPH2 and LPH3, whilst latro-
philin proper was designated LPH1. Complete nucleotide se-
quences of all three LPHs were determined from correspond-
ing overlapping clones. The location of initiation codons in all
bovine cDNAs was facilitated by the fact that, in contrast to
the rat sequence, stop codons are found just upstream of the
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start codons. The deduced amino acid sequences of the three
bovine LPHs aligned with rat LPH1 are shown in Fig. 1A.
3.2. Domain structure and sequence homologies of latrophilins
All LPH proteins have the same architecture (Fig. 1A). The
large extracellular domain begins with a well-de¢ned signal
peptide (SP) attached to a cysteine-rich domain (Lectin) that
resembles some carbohydrate-binding proteins: galactose-spe-
ci¢c lectin from sea urchin (SwissProt: P22031) and L-galac-
tosidase (P45582). The Lectin domain is connected to an ex-
tended sequence (Olf) homologous to olfactomedin (Q07081),
neuronal olfactomedin-related protein (Q62609, Q99784) and
to myocilin (Q99972). Olfactomedin is found in olfactory epi-
thelium and has been implicated in odorant binding [17]. My-
ocilin is predominantly expressed in retina; mutations in its
functionally important region, which is homologous to olfac-
tomedin and LPH, are associated with glaucoma [18]. The
olfactomedin domain Olf is followed by a proline/threonine-
rich sequence (Pro/Thr) and a Linker domain, which both
have no substantial (above 20%) sequence homology to pro-
teins in databases. A short stretch of residues at the borderline
between the Pro/Thr and the Linker (termed Signature) can
also be found in receptors of corticotropin-releasing factor,
growth hormone-releasing factor, vasoactive intestinal pep-
tide, secretin, and parathyroid hormone. These receptors, to-
gether with LPH, belong to the secretin/calcitonin family of
GPCRs. The Pro/Thr and the Linker connect the olfactome-
din domain with a region (Long) that lies immediately up-
stream of the transmembrane domains and is distantly similar
to such ‘long’ GPCRs as CD97 (P48960) and EMR1
(Q61549). At the C-terminal part, just next to the membrane,
the Long contains a conserved pattern (4Cys) with four cys-
teines residues CxFW....GxWxxxGC.....CxCxHLTxFA(I/
V)LM (where x denotes any amino acid and dots represent
variable number of residues). This pattern is present in a
similar, near-membrane position in many GPCRs and could
determine the site of proteolytic degradation that may occur
in LPH1 under certain conditions [10]. The seven transmem-
brane regions (TMRs) bear substantial homology to all
GPCRs of the secretin/calcitonin family. These receptors
have been shown to participate in various secretory processes
mediated by G proteins. The C-terminal cytoplasmic sequence
(Cytoplasm) does not exhibit any distinct domain structure,
except that it contains multiple potential sites of phosphoryl-
ation and palmitoylation and several PEST regions. PEST
regions (rich in prolines, glutamic acids, serines and threo-
nines) confer susceptibility to rapid proteolysis [19^21], and
many proteins that contain such a motif may be extraordi-
narily short-lived. There are three possible PEST regions in
LPH1, two in LPH2 and one in LPH3 (Fig. 1), suggesting
that the C-terminus of LPH1 may be prone to fast degrada-
tion consistent with our observation of its very labile charac-
ter (unpublished).
At the amino acid level, bovine LPH1 is highly homologous
to the rat protein (98.3% of identical amino acid residues).
Furthermore, the LPH1 extracellular domains are almost
identical in the two species (99.4%). The overall similarity
between all three bovine LPH homologues is also substantial
and ranges from 70 to 75%. Thus, LPH proteins of the same
type from di¡erent animal species are much more alike than
di¡erent LPH types within the same species, indicating a high
degree of specialisation and distinct functions. The distribu-
tion of evolutionarily invariable residues is uneven along the
molecule. The highest sequence conservation is found in the
Lectin domains (80^87%), suggesting that this LPH region is
important for receptor functioning, e.g. it could interact with
some glycosylated proteins. The Olf domains, Linkers, Long
regions, TMRs and the upstream thirds of the cytoplasmic
domains all display 60^75% identity. In contrast, the Pro/
Thr domains as well as the large distal parts of the C-termini
of LPHs are much more divergent (20^40% homology) and
may have evolved to carry out diverse functions.
3.3. Extensive alternative splicing
One of the interesting features of LPHs is the presence of
multiple splice sites that can alter the proteins by introducing
insertions or deletions in both the extracellular and the cyto-
plasmic domains. Positions of some splice sites seem to be
conserved among LPHs; based on this observation and on
partial genomic sequences of these proteins, we postulate sev-
en potential sites of alternative splicing (Fig. 1B). Considering
a very elaborate intron-exon structure of the LPH genes (un-
published), it is likely that other splice sites also exist that
have not been identi¢ed in this work. Of the seven splice sites,
four are located in the extracellular domain, at the borders of
the Lectin and Olf domains. These sites have a simpli¢ed
repertoire of alterations: they usually bring about either a
deletion or an insert, which sometimes may be large (Fig.
1A). The splicing pattern in the cytoplasmic parts of LPH is
usually more elaborate. Thus, up to three di¡erent variants of
inserts can be introduced in the third cytoplasmic loop of
LPH2 (splice site 5). These are likely to substantially modify
the coupling and G protein-mediated signalling of this GPCR.
The most striking, however, is the splice site 7. We found that
some of the inserts present at this position in LPH2 and 3
cause a frame shift and occurrence of stop codons soon after
the insert and long before the usual end of the sequence. This
results in the translation of a C-terminally truncated protein
and may signi¢cantly a¡ect the protein’s stability, targeting
and/or signalling. Not all possible alternative splicing is real-
ised in each gene. In contrast to LPH2, LPH3 and, especially,
LPH1 are conserved. In LPH1, we were able to ¢nd only one
position in the extracellular domain (splice site 2) where an
insert of just ¢ve amino acids may be spliced in or out. In
LPH3, in addition to a similar ¢ve-residue insert at splice site
2, sixty-seven amino acid residues can be introduced (or re-
moved) at splice site 1, immediately downstream of the signal
peptide (Fig. 1A). The conservation of the extracellular se-
quences of LPH1 and 3 could mean that they have important
and specialised functions, di¡erent from those of LPH2, and
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Fig. 1. The structure of latrophilins. A: Alignment of deduced amino acid sequences of rat LPH1 [11] and bovine LPH1, 2 and 3. Residues
identical to those of bovine LPH1 are shaded; di¡erent shades of grey are used to distinguish the LPH domains, which are labelled above the
sequences (see text). Residues that can be spliced out at indicated sites are shown in bold and crossed out. Asterisks denote stop codons, puta-
tive PEST regions are underscored. B: Multiple alternative splicing of latrophilins. LPH proteins are schematically presented with the structural
domains shaded as in A. Triangles represent inserts of variable sizes found in respective positions in several independent clones.
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are under evolutionary pressure to keep their structure un-
changed. Another striking observation is the presence of a
stop codon in the rare insert C at splice site 2 of LPH1
(Fig. 1A). The N-terminal Lectin domain in this case must
be released and could function as a soluble ligand of some
receptors.
3.4. Distribution of latrophilins and their interaction with
K-latrotoxin
Northern blotting of RNA isolated from di¡erent rat tis-
sues with probes speci¢c for LPH1, 2 and 3, revealed that
both LPH1 and 3 are almost exclusively brain-speci¢c,
although LPH3 is in general much more scarce (Fig. 2). Ex-
ceedingly low amounts of LPH1 were found also in kidney,
lung and spleen, but not in muscle, liver or duodenum. This
may be due to the presence of neuronal or endocrine cells in
these preparations. Indeed, LTX is known to stimulate latro-
philin-mediated secretion from adrenal chroma⁄n cells and
pancreatic L-cells [5,16]. Alternatively, since LPH1 has been
implicated in secretion [10,11,22], very low levels of LPH1
expression may be needed for many cells to regulate their
exo- or endocytic functions. Curiously, another LTX receptor,
neurexin is expressed in appreciable amounts not only in brain
but also in other tissues, mostly in lung (data not shown).
LTX, however, does not appreciably interact with non-neuro-
nal or non-endocrine tissues, nor does it bind to COS cells
that are derived from kidney cells. Probably, the toxin re-
quires a certain concentration of receptors (LPH and/or neu-
rexin) to bind to the cell surface. It is also possible that in
non-neuronal tissues that have a very low level of LPH1
mRNA, the protein is not translated or not properly modi¢ed
and/or targeted. Considering that LPH1 is at least 50 fold
more abundant in brain than in any other tissue and that
its localisation in the nervous system is restricted to nerve
terminals (to be published), it may have a highly specialised
function. LPH3, too, is evident outside brain, namely in lung
and spleen. In contrast, the distribution of LPH2 is radically
di¡erent (Fig. 2). This ubiquitous protein appears to be prev-
alent in liver but is also abundant in lung and brain and is
expressed to variable extent in all tissues tested.
In order to extend the observations made at the RNA level
to the level of proteins, we performed immunoblotting of
brain and liver membranes, using an antibody against the
extracellular domain of LPH1. As demonstrated in Fig. 3,
this antibody recognised both LPH1 and LPH2, which are
abundant in brain and liver, respectively. We were able to
distinguish between the two proteins because of the di¡erence
in their molecular masses, which is most likely due to di¡er-
ential proteolysis. No LPH1 was detected in liver and, recip-
rocally, no LPH2 could be seen in brain (Fig. 3). In spite of
the similar primary and domain structures of LPH1 and 2,
LTX a⁄nity chromatography of brain and liver membranes
(Fig. 3) produced only LPH1 and only from brain but not
from liver. This indicates that although LPH2 is abundant in
liver, it cannot serve as LTX receptor. Vice versa, although
the toxin strongly binds to the receptor, it is unable to con-
centrate any detectable amount of LPH1 from liver. As a
control of speci¢city of the chromatographic procedure, an-
other tissue (cerebellum) that contains substantial amounts of
LPH1 was used. In full agreement with the toxin binding
data, the concentration of LPH1 in cerebellum was three to
four fold lower than in brain; this ratio was also preserved in
the course of a⁄nity chromatography (Fig. 3). Based on the
absence of LPH3 sequences among the 18 peptides isolated
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Fig. 2. Northern blot analysis of latrophilins. Rat multi-tissue RNA blots were hybridised to radiolabelled bovine cDNA probes speci¢c for
LPH1, 2 or 3, as indicated. Positions and sizes (in kbp) of RNA standards are shown on the sides.
Fig. 3. Left: Immunostaining of LPH1 and LPH2 in the plasma
membranes from bovine brain, cerebellum and liver. Membrane pro-
teins were separated by SDS-electrophoresis and electroblotted and
stained with an anti-LPH1 antibody. Right: A⁄nity chromatogra-
phy of solubilised membranes from the same tissues on immobilised
LTX. Membranes from bovine tissues were solubilised and passed
through the LTX column [11]; eluted proteins were analysed by
SDS-electrophoresis with Coomassie blue detection. Positions and
molecular masses (in kDa) of standard proteins are shown on the
left; the arrow indicates LPH1.
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from the receptor puri¢ed from brain, LPH3 is also unlikely
to bind the toxin.
In conclusion, the experiments reported in this paper de-
scribe a novel family of latrophilin-related proteins. These
proteins display fascinating common structural features: com-
plex domain structure, potential to couple to G proteins and
multiple alternative splicing. However, their di¡erential distri-
bution in the organism, type-speci¢c evolutionary preserva-
tion and binding of LTX by only one member of the family
suggest that LPH proteins have distinct functions. Despite
their similarities, LPHs are likely to interact with di¡erent
ligands. Future work will concentrate on the functions of
these interesting receptors and their endogenous ligands.
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